FR2806623A1 - Active principle extracted from nasturtium used in cosmetic formulations for the depigmenting and lightening of the skin - Google Patents
Active principle extracted from nasturtium used in cosmetic formulations for the depigmenting and lightening of the skin Download PDFInfo
- Publication number
- FR2806623A1 FR2806623A1 FR0003718A FR0003718A FR2806623A1 FR 2806623 A1 FR2806623 A1 FR 2806623A1 FR 0003718 A FR0003718 A FR 0003718A FR 0003718 A FR0003718 A FR 0003718A FR 2806623 A1 FR2806623 A1 FR 2806623A1
- Authority
- FR
- France
- Prior art keywords
- active ingredient
- nasturtiums
- skin
- depigmenting
- active principle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
PROCEDE <B>D'EXTRACTION D'UN PRINCIPE ACTIF A PARTIR DE</B> <B>CAPUCINES, NOTAMMENT POUR LE TRAITEMENT DE LA PIGMENTATION,</B> <B>PRINCIPE ACTIF OBTENU, COMPOSITIONS</B> COSMETIQUES <B>OBTENUES</B> La présente invention concerne un procédé d'extraction principe actif à partir capucines, notamment pour le traitement de la pigmentation. L'invention couvre aussi le principe actif obtenu et les compositions cosmétiques utilisant ledit principe actif. PROCESS FOR EXTRACTING AN ACTIVE INGREDIENT FROM CAPUCINES, IN PARTICULAR FOR THE TREATMENT OF PIGMENTATION, ACTIVE INGREDIENT, COMPOSITIONS </ B> COSMETICS </ B> The present invention relates to a method for extracting active ingredient from nasturtiums, in particular for the treatment of pigmentation. The invention also covers the active ingredient obtained and the cosmetic compositions using said active ingredient.
On sait la peau, les cheveux, les poils sont colorés un pigment synthétisé mélanocytes : la mélanine. We know the skin, the hair, the hair is colored a pigment synthesized melanocytes: melanin.
La melanogénèse relève de mécanismes complexes mais façon générale, la synthèse des mélanocytes est effectuée par l'organisme façon adaptée pour assurer une bonne protection contre les radiations solaires. Melanogenesis is a complex mechanism, but in general, the synthesis of melanocytes is carried out by the body, which is adapted to ensure good protection against solar radiation.
Néanmoins, lors de dérèglements, il se produit une hyperpigmentation qui conduit a formation de tâches de rousseur, de sénescence, chloasma ou masque de grossesse. Nevertheless, during dysregulations, hyperpigmentation occurs which leads to the formation of freckles, senescence, chloasma or pregnancy mask.
Ces troubles de la pigmentation peuvent survenir avec l'âge, nature de la peau ou perturbations hormonales. These pigmentation disorders can occur with age, nature of the skin or hormonal disturbances.
Des études ont montré que dans les cas d'hyperpigmentation, l'augmentation la mélanogénèse s'accompagne d'une augmentation de l'activité de la tyrosinase. Studies have shown that in cases of hyperpigmentation, increased melanogenesis is accompanied by an increase in tyrosinase activity.
II faut donc agir sur trois fronts simultanément - bloquer I activité des mélanocytes, - orienter synthèse de phaeomélanines, et - inhiber<B>1</B> activité de la tyrosinase. Les dérivés phénoliques, par exemple l'hydroquinone, ont des propriétés dépigmentantes mais présentent de nombreux inconvénients. Ces composés ne sont en effet utilisables qu'en faible concentration et à cette faible concentration, l'activité est irrégulière, la cytotoxicité est élevée et même des effets secondaires peuvent être observés. It is therefore necessary to act on three fronts simultaneously - to block the activity of melanocytes, to orient synthesis of phaeomelanins, and to inhibit tyrosinase activity. Phenolic derivatives, for example hydroquinone, have depigmenting properties but have many disadvantages. These compounds can only be used in low concentration and at this low concentration, the activity is irregular, the cytotoxicity is high and even side effects can be observed.
Pour traiter de tels effets, on est à la recherche d'autres composes dépigmentants. Les autres produits actuellement connus comme l' oxygénée produisent des effets éclaircissants, notamment sur les poils et les cheveux, mais ils sont difficiles à utiliser en cosmétique pour des raisons de toxicité, de tolérance et de difficulté de mise en oeuvre. D'autres produits susceptibles de donner des effets dépigmentants sont instables ou non tolérés, ce qui exclut leur utilisation en cosmétologie. To treat such effects, one is looking for other depigmenting compounds. Other products currently known as oxygenate produce lightening effects, especially on hair and hair, but they are difficult to use in cosmetics for reasons of toxicity, tolerance and difficulty of implementation. Other products likely to give depigmenting effects are unstable or not tolerated, which excludes their use in cosmetology.
La présente invention vise à proposer un procédé d'extraction d'un principe actif qui produit des effets dépigmentants de la peau, à partir de végétaux, en l'occurrence à partir de fleurs de capucines. The present invention aims to provide a method of extracting an active ingredient that produces depigmenting effects of the skin, from plants, in this case from nasturtium flowers.
Comme il s'agit de produits naturels et totalement contrôlés, cytotoxicité est nulle et les effets secondaires tels que irritation, allergie autres instabilités sont parfaitement contrôlées. As it is natural products and totally controlled, cytotoxicity is zero and side effects such as irritation, allergy other instabilities are perfectly controlled.
L'invention couvre aussi le principe actif obtenu par ce procédé et moins une composition cosmétique mettant en oeuvre ce principe actif. The invention also covers the active ingredient obtained by this process and less a cosmetic composition using this active ingredient.
La présente invention couvre aussi l'utilisation de ces compositions pour obtenir des effets dépigmentants et éclaircissants de la peau. The present invention also covers the use of these compositions to obtain depigmenting and lightening effects of the skin.
La présente invention est maintenant décrite en détail en explicitant effets recherchés et obtenus grâce au principe actif extrait. The present invention is now described in detail by explaining desired effects and obtained through the extracted active ingredient.
Les différentes figures 1, 2 et 3 annexées regroupent les résultats obtenus pour les différents tests. The various figures 1, 2 and 3 annexed group together the results obtained for the different tests.
II PROCEDE <U>D'EXTRACTION</U> Le procédé d'extraction selon la présente invention comprend les étapes suivantes - décoction de poudre de plante entière de capucines dans l'eau à raison d'au moins 50 g/1, - séparation des phases soluble et insoluble, - concentration de la fraction active contenue dans la phase soluble, - filtration stérilisante. EXTRACTION PROCESS The extraction method according to the present invention comprises the following steps: decoction of whole plant powder of nasturtiums in water in a proportion of at least 50 g / l; separation of the soluble and insoluble phases, concentration of the active fraction contained in the soluble phase, sterilizing filtration.
De préférence, il est utilisé uniquement les parties florales de capucines. La séparation mise en oeuvre est une filtration, une centrifugation une décantation. Preferably, only the floral parts of nasturtiums are used. The separation used is filtration, centrifugation and decantation.
II/ CARACTERISATION <U>DU PRINCIPE ACTIF</U> Le principe actif ainsi obtenu est caractérisé par les paramètres analytiques suivants <U>I Matière sèche</U> Taux de matière sèche : compris entre 20 et 400 g/1 plus particulièrement entre 20 et 200 g/1 principalement entre 60 et 80 g/1. Ce taux est obtenu par passage à l'étuve à 105 C jusqu'à obtention d'un poids constant, <U>2/ pH</U> La valeur du pH est comprise entre 4,0 et 10,0 plus particulièrement entre 4,0 et 8,0, notamment entre 5,0 et 6,0, obtenue par la méthode potentiométrique, à température ambiante. II / CHARACTERIZATION <U> OF THE ACTIVE PRINCIPLE </ U> The active principle thus obtained is characterized by the following analytical parameters <U> I Dry matter </ U> Dry matter content: between 20 and 400 g / 1 more particularly between 20 and 200 g / l, mainly between 60 and 80 g / l. This rate is obtained by passing in an oven at 105 ° C. until a constant weight is obtained. <U> 2 / pH </ U> The pH value is between 4.0 and 10.0, more particularly between 4.0 and 8.0, in particular between 5.0 and 6.0, obtained by the potentiometric method, at room temperature.
<U>3/</U> Polyphénols <U>totaux</U> composés phénoliques forment des complexes colorés en présence de ferricyanure de potassium, dont l'intensité peut-être détectée à 715 nm. Ceci permet de déterminer la quantité de composés phénoliques sur une courbe étalon. Cette courbe est obtenue à partir d'une gamme étalon d'acide gallique allant de 40 à 120 mg/I. <U> 3 / </ U> Polyphenols <U> total </ U> Phenolic compounds form colored complexes in the presence of potassium ferricyanide, the intensity of which can be detected at 715 nm. This makes it possible to determine the amount of phenolic compounds on a standard curve. This curve is obtained from a standard range of gallic acid ranging from 40 to 120 mg / l.
La teneur en composés phénoliques est ainsi exprimée en mg d'acide gallique. The content of phenolic compounds is thus expressed in mg of gallic acid.
La valeur obtenue est comprise entre 50 et 5 000 mg/l, plus particulièrement entre 50 et 2 500 mg/I, notamment entre 70 et 2000 mg/I. The value obtained is between 50 and 5000 mg / l, more particularly between 50 and 2500 mg / l, in particular between 70 and 2000 mg / l.
<U>/ Stabilité</U> le principe actif est stable aux pH de 2 à 10 et aux températures inférieures à<B>800C.</B> - le principe actif est stable dans un mélange d'éthanol et d'eau avec des proportions fortes d'éthanol jusqu'à 60 pour des quantités en volume de 3% de principe actif, à 20 C et au pH de solution. <U> / Stability </ U> the active ingredient is stable at pH 2 to 10 and at temperatures below <B> 800C. </ B> - the active ingredient is stable in a mixture of ethanol and water with high proportions of ethanol up to 60 for volume quantities of 3% of active ingredient, at 20 ° C. and at the pH of the solution.
III/<U>EFFETS</U> DEPIGMENTANTS <U>DU PRINCIPE ACTIF EXTRAIT</U> <U>1l</U> Evaluation <I><U>in vitro</U></I><U> de l'activité</U> dépiamentante On procède à l'étude de cette activité des cultures de mélanocytes en mesurant d'une part l'activité anti-tyrosinase du principe actif selon la présente invention et d'autre part le taux de melanine synthétisée en présence de ce même principe actif. III / <U> EFFECTS </ U> DEPIGMENTING <U> OF THE ACTIVE PRINCIPLE EXTRACT </ U> <U> 1l </ U> Evaluation <I> <U> in vitro </ U> </ I> <U> This activity of the melanocyte cultures is measured by measuring, on the one hand, the anti-tyrosinase activity of the active ingredient according to the present invention and, on the other hand, the level of melanin. synthesized in the presence of this same active ingredient.
On peut comparer ces résultats avec ceux obtenus avec un témoin positif tel que l'acide kojique à 0,5 g/1 et un polyphénols constitutifs du principe actif, l'acide para-coumarique. These results can be compared with those obtained with a positive control such as kojic acid at 0.5 g / l and a polyphenols constituting the active ingredient, para-coumaric acid.
Dans des cultures de mélanocytes, on ajoute soit 1, 2 et 3% de principe actif selon la présente invention, soit de l'acide kojique à 0,5 g/l, soit encore de l'acide para-coumarique à 10 g/1. In melanocyte cultures, one adds either 1, 2 and 3% of active principle according to the present invention, either kojic acid to 0.5 g / l, or again para-coumaric acid to 10 g / 1.
Après incubation, on procède à une trypsination cellulaire de chaque culture. Les culots cellulaires sont lysés puis centrifugés. After incubation, a cell trypsination of each culture is carried out. The cell pellets are lysed and then centrifuged.
Le surnageant est récupéré pour le dosage de la tyrosinase et le culot restant est utilisé pour le dosage du taux de mélanine. The supernatant is recovered for the determination of tyrosinase and the remaining pellet is used for the determination of the melanin level.
<U>1.1 Dosage de la</U> tyrosinase On ajoute au surnageant de la L-DOPA dans un tampon phosphate et on mesure l'activité enzymatique de la tyrosinase à 490 nm. <U> 1.1 Tyrosinase Assay L-DOPA supernatant was added to phosphate buffer and the enzyme activity of tyrosinase was measured at 490 nm.
Les résultats sont exprimés dans le tableau de la figure 1 qui représente les résultats obtenus. On constate que l'acide kojique (ak), qui est la référence, conduit à un résultat de 63 % d'activité anti-tyrosinase et que le principe actif (PA) selon l'invention, à 3%, présente un résultat supérieur à 72%. The results are expressed in the table of FIG. 1 which represents the results obtained. It is found that kojic acid (ak), which is the reference, leads to a result of 63% anti-tyrosinase activity and that the active ingredient (PA) according to the invention, at 3%, has a superior result. at 72%.
Dès 2%, on note que le principe actif selon la présente invention est supérieur à l'acide para-coumarique à 10g/1 (ap). From 2%, it is noted that the active ingredient according to the present invention is greater than para-coumaric acid at 10 g / l (ap).
On constate que le principe actif selon la présente invention procure un effet inhibant de l'activité de la tyrosinase, enzyme de la mélanogénèse. Cet effet inhibant se traduit par une activité dépigmentante proche de celle l'acide kojique qui est la molécule de référence. It is found that the active ingredient according to the present invention provides an inhibiting effect of the tyrosinase activity, enzyme of melanogenesis. This inhibiting effect results in a depigmenting activity close to that of kojic acid which is the reference molecule.
<U>1.2 Dosage de la mélanine synthétisée</U> taux de mélanine des échantillons est déterminé au moyen d'une gamme étalon de mélanine synthétique de 0 à 500,ug/ml. <U> 1.2 Determination of melanin synthesized </ U> melanin level of the samples is determined by means of a standard range of synthetic melanin from 0 to 500 μg / ml.
Les résultats sont indiqués dans le tableau de la figure 2. The results are shown in the table of Figure 2.
constate une diminution importante du taux de synthèse de la mélanine quasiment identique à celui de l'acide kojique (ak) et de l'acide para- coumarique (ap), dès 2 % de principe actif (PA) selon la présente invention. found a significant decrease in the synthesis rate of melanin almost identical to that of kojic acid (ak) and para-coumaric acid (ap), from 2% of active ingredient (PA) according to the present invention.
Par sa richesse en polyphénols, le principe actif assure une inhibition certaine de la synthèse de la mélanine. Because of its high content of polyphenols, the active principle ensures a certain inhibition of the synthesis of melanin.
<U>2I</U> Etudes <U>cutanées des effets</U> dépigmentants Cette étude consiste à mette en évidence sur l'homme, variations de la couleur des tâches de sénescence cutanée sur le dos de la main. <U> 2I </ U> <U> Skin studies of depigmenting effects </ U> This study consists in highlighting on the man, variations of the color of the cutaneous senescence spots on the back of the hand.
Dans le cadre de l'essai, le principe actif selon 1a présente invention est formulé à 5 % en crème blanche. In the context of the test, the active ingredient according to the present invention is formulated with 5% white cream.
Pour mesurer ces variations, on utilise un chromamètre commerce qui convertit les couleurs situées dans la plage de perception humaine en un code numérique à deux paramètres l'un L d'intensité (sombre au pâle) et l'autre _b de chrominance (gamme des bleus aux jaunes). To measure these variations, a commercial chromameter is used which converts the colors in the human perception range into a two-parameter numerical code, one L intensity (dark to pale) and the other chrominance _b (gamut range). blue to yellow).
On mesure les paramètres colorimétriques des tâches sénescence de chaque personne testée, ceci avant le traitement. Une main ensuite est traitée avec placebo et l'autre est traitée avec la crème contenant principe actif selon la présente invention. The colorimetric parameters of the senescence tasks of each person tested are measured before the treatment. One hand is then treated with placebo and the other is treated with the cream containing active ingredient according to the present invention.
L'application est effectuée deux fois par jour pendant plusieurs semaines, en l'occurrence huit semaines. The application is made twice a day for several weeks, in this case eight weeks.
Les paramètres colorimétriques des tâches retenues sont à nouveau mesurés. The colorimetric parameters of the tasks retained are again measured.
Les résultats sont regroupés dans le tableau de la figure 3. L'étude est effectuée sur 15 volontaires et le tableau fait apparaître les moyennes obtenues. constate la diminution significative du paramètre de chrominance b_ -0, et une augmentation de l'intensité _L de 0,26% tâches de sénescence apparaissent moins colorées pour 78% volontaires. The results are shown in the table in Figure 3. The study is carried out on 15 volunteers and the table shows the averages obtained. found the significant decrease in the chrominance parameter b_ -0, and an increase in intensity _L of 0.26% senescence tasks appear less colored for 78% volunteers.
sa richesse en polyphénols, le principe actif inhibe la tyrosinase est l'enzyme-clé de la mélanogénèse et limite la synthèse de la mélanine. plus, ce principe actif est stable, non irritant et non cytotoxique. its richness in polyphenols, the active ingredient inhibits tyrosinase is the key enzyme of melanogenesis and limits the synthesis of melanin. Moreover, this active ingredient is stable, non-irritating and non-cytotoxic.
principe actif peut être utilisé avec toute formulation telle que crème, onguent, lotion, lait, émulsion ou solution, à raison d'une quantité de principe actif compris entre 0,1 et<I>20 l0.</I>the active ingredient can be used with any formulation such as cream, ointment, lotion, milk, emulsion or solution, in the amount of an amount of active ingredient of between 0.1 and <I> 20 l0. </ i>
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0003718A FR2806623B1 (en) | 2000-03-23 | 2000-03-23 | PROCESS FOR EXTRACTING AN ACTIVE INGREDIENT FROM CAPUCINS, PARTICULARLY FOR THE TREATMENT OF PIGMENTATION, ACTIVE INGREDIENT OBTAINED, COSMETIC COMPOSITIONS OBTAINED |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0003718A FR2806623B1 (en) | 2000-03-23 | 2000-03-23 | PROCESS FOR EXTRACTING AN ACTIVE INGREDIENT FROM CAPUCINS, PARTICULARLY FOR THE TREATMENT OF PIGMENTATION, ACTIVE INGREDIENT OBTAINED, COSMETIC COMPOSITIONS OBTAINED |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2806623A1 true FR2806623A1 (en) | 2001-09-28 |
FR2806623B1 FR2806623B1 (en) | 2002-05-17 |
Family
ID=8848423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0003718A Expired - Lifetime FR2806623B1 (en) | 2000-03-23 | 2000-03-23 | PROCESS FOR EXTRACTING AN ACTIVE INGREDIENT FROM CAPUCINS, PARTICULARLY FOR THE TREATMENT OF PIGMENTATION, ACTIVE INGREDIENT OBTAINED, COSMETIC COMPOSITIONS OBTAINED |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2806623B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2834462A1 (en) * | 2002-01-08 | 2003-07-11 | Silab Sa | Production of a plant-derived active ingredient useful in cosmetic moisturizing products comprises enzymatic hydrolysis of an aqueous dispersion of watercress powder |
FR2845284A1 (en) * | 2002-10-07 | 2004-04-09 | Silab Sa | Producing an agent for enhancing melanin synthesis, useful for skin tanning, comprises dissolving powdered restharrow root in aqueous alcohol, separating the soluble and insoluble phases and concentrating the polyphenol phase |
FR2965483A1 (en) * | 2010-10-04 | 2012-04-06 | Silab Sa | COSMETIC USE OF A TROPAEOLUM MAJUS EXTRACT AS AN ACTIVE INGREDIENT TO PROMOTE OXYGENATION OF SKIN TISSUE |
US9283170B2 (en) | 2010-05-18 | 2016-03-15 | Conopco, Inc. | Personal care composition |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH492593A (en) * | 1964-07-13 | 1970-06-30 | Malsen Egbert Von | Skin care products |
JPH0549432A (en) * | 1991-08-23 | 1993-03-02 | Takano Co Ltd | Food additive |
JPH0725763A (en) * | 1993-07-14 | 1995-01-27 | Sansho Seiyaku Co Ltd | Deramatic agent for external use |
JPH1192353A (en) * | 1997-09-19 | 1999-04-06 | Kao Corp | Skin preparation for external use for inhibiting sebum synthesis |
FR2779346A1 (en) * | 1998-06-04 | 1999-12-10 | Silab Sa | Plant extract for preventing and treating effects of solar radiation on skin and hair |
-
2000
- 2000-03-23 FR FR0003718A patent/FR2806623B1/en not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH492593A (en) * | 1964-07-13 | 1970-06-30 | Malsen Egbert Von | Skin care products |
JPH0549432A (en) * | 1991-08-23 | 1993-03-02 | Takano Co Ltd | Food additive |
JPH0725763A (en) * | 1993-07-14 | 1995-01-27 | Sansho Seiyaku Co Ltd | Deramatic agent for external use |
JPH1192353A (en) * | 1997-09-19 | 1999-04-06 | Kao Corp | Skin preparation for external use for inhibiting sebum synthesis |
FR2779346A1 (en) * | 1998-06-04 | 1999-12-10 | Silab Sa | Plant extract for preventing and treating effects of solar radiation on skin and hair |
Non-Patent Citations (3)
Title |
---|
DATABASE WPI Week 199514, Derwent World Patents Index; AN 1995-101794, XP002147746 * |
PATENT ABSTRACTS OF JAPAN vol. 017, no. 349 (C - 1078) * |
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 09 (C - ) * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2834462A1 (en) * | 2002-01-08 | 2003-07-11 | Silab Sa | Production of a plant-derived active ingredient useful in cosmetic moisturizing products comprises enzymatic hydrolysis of an aqueous dispersion of watercress powder |
FR2845284A1 (en) * | 2002-10-07 | 2004-04-09 | Silab Sa | Producing an agent for enhancing melanin synthesis, useful for skin tanning, comprises dissolving powdered restharrow root in aqueous alcohol, separating the soluble and insoluble phases and concentrating the polyphenol phase |
WO2004032892A1 (en) * | 2002-10-07 | 2004-04-22 | Societe Industrielle Limousine D'application Biologique (Silab) | Method for obtaining an active principle having a skin pigmenting activity, resulting active principle and cosmetic composition comprising same |
US9283170B2 (en) | 2010-05-18 | 2016-03-15 | Conopco, Inc. | Personal care composition |
FR2965483A1 (en) * | 2010-10-04 | 2012-04-06 | Silab Sa | COSMETIC USE OF A TROPAEOLUM MAJUS EXTRACT AS AN ACTIVE INGREDIENT TO PROMOTE OXYGENATION OF SKIN TISSUE |
WO2012045974A2 (en) | 2010-10-04 | 2012-04-12 | Societe Industrielle Limousine D'application Biologique | Cosmetic use of a tropaeolum majus extract as an active principle for promoting the oxygenation of skin tissue |
WO2012045974A3 (en) * | 2010-10-04 | 2012-10-18 | Societe Industrielle Limousine D'application Biologique | Cosmetic use of a tropaeolum majus extract as an active principle for promoting the oxygenation of skin tissue |
Also Published As
Publication number | Publication date |
---|---|
FR2806623B1 (en) | 2002-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2286409C (en) | Cosmetic and/or dermatological compound containing at least one extract of blackberry, at least one extract of skullcap and at least one salicylic acid derivative | |
CA2044269C (en) | Cafeic acid based pharmaceutical and cosmetic depigmenting compositions | |
FR2730408A1 (en) | COMPOSITIONS WITH DEPIGMENTING ACTIVITY AND APPLICATIONS THEREOF | |
EP1401383A2 (en) | Use of at least an oil extracted from the seeds of the gourd family for preparing a composition for inhibiting 5-alpha-reductase activity | |
CA2721196C (en) | Use of myrtle extract as depigmenting agent | |
JPH04342519A (en) | Skin cosmetic | |
CA2281193C (en) | Use of at least one extract of rosaceae, genus sanguisorba officinalis, to promote pigmentation of the skin, hair and/or body hair | |
EP0820763B1 (en) | Use of N,N'-dibenzyl-ethylene diamine acid derivatives as depigmentation agents | |
FR2806623A1 (en) | Active principle extracted from nasturtium used in cosmetic formulations for the depigmenting and lightening of the skin | |
FR2825022A1 (en) | Nontherapeutic treatment of the human or animal body comprises administering or applying olive polyphenols | |
WO2022254116A1 (en) | Cosmetic use of an oily extract from solid residue of immortelle as a skin brightening agent | |
EP1566168B1 (en) | Dermo-cosmetic compositions for depigmenting and use of it | |
FR3089974A1 (en) | New depigmenting compounds extracted from Eryngium maritimum | |
JP2006265141A (en) | Skin-whitening agent | |
FR2796549A1 (en) | USE OF AT LEAST ONE EXTRACT FROM A PLANT OF THE GENUS LANNEA IN A COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION | |
TWI477292B (en) | Flatstem milkvetch seed extract for preventing melanin precipitation | |
FR3015281A1 (en) | COSMETIC USE OF AN ESSENTIAL OIL OF LASERPITIUM SILER L. FOR LIGHTENING KERATINIC MATERIALS | |
WO2004032892A1 (en) | Method for obtaining an active principle having a skin pigmenting activity, resulting active principle and cosmetic composition comprising same | |
WO2003061618A1 (en) | Method for obtaining an active principle from agarum cribosum, particularly for prevention of pigmentation | |
TWI474828B (en) | Anisomeles ovate extract for preventing melanin precipitation | |
FR3123569A1 (en) | Rapeseed meal hydrolyzate, method of preparation and use in food and cosmetics, in particular for treating skin aging and depigmenting the skin | |
FR2835747A1 (en) | Production of stable, odorless extract of Synechococcus plankton, with e.g. antiradical and tyrosinase inhibiting activity, useful in topical cosmetic or dermatological compositions, comprises extracting plankton with solvent | |
WO2024104797A1 (en) | Cosmetic use of an extract of immortelle as a skin lightening agent | |
FR3127133A1 (en) | Extract of rapeseed meal, method of preparation and use in cosmetics, in particular as a propigmenting, slimming agent | |
JPH0920636A (en) | Skin preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CJ | Change in legal form | ||
PLFP | Fee payment |
Year of fee payment: 17 |
|
PLFP | Fee payment |
Year of fee payment: 18 |